You need to sign in.
It's quick and easy, and we'll keep you signed in.
If you’re an RCP member or have previously registered for RCP Player, you can sign in with your associated email address.
Date of publication: 3rd Feb, 2021, 2:25 pm (UK)
Video rating: 4.50
Professor Gerry Davies, Professor of infection pharmacology, University of Liverpool. Professor Davies discusses shortening first-line treatment, shortening and simplifying MDR-TB treatment and what the future holds.